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Neutrophils (also known as neutrophilic gran-
ulocytes or polymorphonuclear leukocytes 
[PMNs]) are the most abundant white blood 
cells in the human circulation. They play a crucial 
role in the immune defense against bacterial 
and fungal pathogens, and they also participate 
in the development of the inflammatory reac-
tion (Nathan, 2006). Although neutrophils are 
mostly viewed as playing a beneficial role to the 
host, their improper activation may also lead to 
tissue damage during an autoimmune or exag-
gerated inflammatory reaction (Nathan, 2006; 
Németh and Mócsai, 2012).
Neutrophils participate in antimicrobial 
host defense both as the first line of innate im-
mune defense and as effectors of adaptive im-
munity. They are short-lived cells that usually 
die while performing their antimicrobial func-
tion. Because their primary role is the localiza-
tion and elimination of invading microorganisms 
at any expense, a simplistic view of neutrophils 
being not more than “dumb” suicide killers has 
prevailed for a long time.
A major wave of discoveries during the 1990s 
and early 2000s made immunologists begin to 
appreciate the amazing complexity and sophisti-
cation of neutrophil functions. It became evident 
that neutrophils release cytokines and contrib-
ute to orchestrating the immune/inflammatory 
response (Bazzoni et al., 1991a,b; Cassatella, 
1995). A highly sophisticated machinery di-
recting neutrophil migration (Ley et al., 2007; 
Nourshargh et al., 2010) and a surprising com-
plexity of neutrophil granules (Borregaard et al., 
2007) also begun to emerge. Novel but contro-
versial concepts about how neutrophils may 
fight microbes, including possible regulation of 
granule enzyme function by ion fluxes (Reeves 
et al., 2002) and formation of neutrophil extra-
cellular traps (NETs; Brinkmann et al., 2004) 
were also proposed during that period. Both 
mechanisms have been subject to intense de-
bate (see next section). Nevertheless, all those 
studies indicated that neutrophils use highly 
sophisticated and complex mechanisms to per-
form their role in immune defense and in-
flammation and led to improved and refined 
models of neutrophil biology (Witko-Sarsat 
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Neutrophils have long been considered simple suicide killers at the bottom of the hierarchy 
of the immune response. That view began to change 10–20 yr ago, when the sophisticated 
mechanisms behind how neutrophils locate and eliminate pathogens and regulate immunity 
and inflammation were discovered. The last few years witnessed a new wave of discoveries 
about additional novel and unexpected functions of these cells. Neutrophils have been 
proposed to participate in protection against intracellular pathogens such as viruses and 
mycobacteria. They have been shown to intimately shape the adaptive immune response at 
various levels, including marginal zone B cells, plasmacytoid dendritic cells and T cell popu-
lations, and even to control NK cell homeostasis. Neutrophils have been shown to mediate 
an alternative pathway of systemic anaphylaxis and to participate in allergic skin reactions. 
Finally, neutrophils were found to be involved in physiological and pathological processes 
beyond the immune system, such as diabetes, atherosclerosis, and thrombus formation. 
Many of those functions appear to be related to their unique ability to release neutrophil 
extracellular traps even in the absence of pathogens. This review summarizes those novel 
findings on versatile functions of neutrophils and how they change our view of neutrophil 
biology in health and disease.
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Neutrophil functions: state of the art in the early 2000s
A tremendous amount of knowledge on neutrophils had been 
generated by the end of the 20th century and during the first 
years of the 2000s. The most crucial aspects of that knowl-
edge, which forms the basis of our understanding of neutro-
phil biology, are briefly summarized in the following section 
and in Fig. 1.
Neutrophils are terminally differentiated cells that develop 
in the bone marrow where they are also stored for release into 
the circulation (Borregaard, 2010). During their maturation, 
neutrophils develop several intracellular compartments (secre-
tory granules and vesicles) that store proteins critical for 
the antimicrobial and proinflammatory missions of the cell 
(Borregaard et al., 2007). Once released into the circulation, 
neutrophils begin to seek signs of infection and inflammation 
which lead to a series of events culminating in the migration 
of neutrophils through the vessel wall and inside the tissue 
to the site of microbial invasion (Ley et al., 2007; Nourshargh 
et al., 2010; Fig. 1).
When encountering infectious particles, neutrophils begin 
a professional antimicrobial killing program. The infectious 
particle will be phagocytosed (Nordenfelt and Tapper, 2011) 
and various noxious agents, including reactive oxygen species 
generated through the activity of the NADPH oxidase (Leto 
and Geiszt, 2006), and the contents of intracellular granules 
(Borregaard et al., 2007; Soehnlein, 2009) are then released 
into the phagosome, resulting in killing and digestion of the 
microorganisms (Fig. 1).
Besides the well-established role of phagocytosis, two 
additional mechanisms contributing to neutrophil-mediated 
antimicrobial responses have been proposed during the early 
et al., 2000; Nathan, 2006; Mantovani et al., 2011; Amulic et al., 
2012; Fig. 1).
The last few years have borne witness to another wave of 
discoveries of novel and unexpected roles of neutrophils in di-
verse aspects of immunity and inflammation, as well as beyond 
the traditional scope of the immunological sciences. Those in-
clude novel roles of neutrophils in immunity against intracellu-
lar pathogens such as viruses and intracellular bacteria; shaping 
of adaptive immunity at different levels; and roles in disease 
states previously not associated with neutrophils, such as allergy 
and anaphylaxis, metabolic diseases, atherosclerosis, or throm-
bus formation. Those cases also revealed novel potential roles 
for NETs beyond antimicrobial functions. Many of those studies 
exploited approaches allowing the antibody-mediated deple-
tion of neutrophils by anti-Gr1 or the more neutrophil-specific 
anti-Ly6G antibodies in mice (Daley et al., 2008), or genetic 
manipulations leading to the partial or complete genetic dele-
tion of the neutrophil lineage (Liu et al., 1996; Karsunky et al., 
2002; Hock et al., 2003; Jonsson et al., 2005; Ordoñez-Rueda 
et al., 2012). Though those novel studies have yet to pass the 
scrutiny of the scientific community, they suggest that neutro-
phils may have a much more widespread role in immunity, in-
flammation, and beyond than previously anticipated.
After a brief summary of established and well-known 
(though sometimes debated) neutrophil functions, this review 
will summarize the novel biological functions of neutrophils 
revealed in the last few years, within and beyond immunity 
and inflammation. I will primarily focus on what neutrophils 
do rather than how they do it. Readers will be referred to ad-
ditional recent reviews on related subjects such as certain aspects 
of the molecular mechanisms of neutrophil functions.
Figure 1. Neutrophil functions: state of 
the art in the early 2000s. After migrating 
to the site of inflammation, neutrophils (PMN) 
phagocytose and digest the invading mi-
crobes; release NETs, which likely trap bacte-
ria; and produce cytokines, which contribute 
to the inflammatory reaction. Once infection 
is cleared, neutrophils die by apoptosis and 
trigger an active program to resolve inflam-
mation. Inset, pathogen killing inside the 
phagosome occurs by ROS generated by the 
NADPH oxidase, as well as by granule en-
zymes released from intracellular granules. 
The NADPH oxidase also induces depolariza-
tion of the phagosomal membrane, which 
may be required for providing optimal envi-
ronment inside the phagosome.
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neutrophil-derived NETs were able to capture HIV-1 particles 
and reduce their efficiency to infect T cells. Most importantly, 
when neutrophils and T cells were co-cultured, neutrophils 
were able to reduce the infection efficiency of HIV-1. Phar-
macological studies indicated that NET formation was de-
pendent on TLR7 and TLR8 in endocytic compartments 
and that the effect of neutrophil-derived NETs on T cells 
could be inhibited by DNase treatment, underscoring the role 
of extracellular DNA. In agreement with those findings, 
the neutrophil-mediated inhibition of HIV-1 infectivity on 
T cells required TLR7 and TLR8, and it was suspended by 
DNase treatment.
Another recent study provided additional evidence for 
the role of neutrophils and NETs in antiviral host defense 
(Jenne et al., 2013). Systemic injection of viral TLR ligands 
or poxvirus infection led to dramatic accumulation of neu-
trophils in liver sinusoids that formed aggregates with plate-
lets and released NETs inside the vessels. Importantly, DNase 
treatment increased the percentage of liver cells infected with 
poxviruses, suggesting that extracellular DNA exerts a protec-
tive effect against viral infection (Jenne et al., 2013).
Although the aforementioned studies suggest a role for 
neutrophils and NETs in antiviral host defense, they also raise 
several questions. Most studies on NET formation by neutro-
phils indicate a critical role for NADPH oxidase activity in 
that process (including the original NET study [Brinkmann 
et al., 2004] where NET formation was triggered by phorbol 
ester-induced activation of neutrophils) and it is difficult 
to envisage how viral particles would be able to trigger such 
a strong stimulation of neutrophils. However, because NET 
formation in the absence of NADPH oxidase activity has 
recently been shown to occur under milder and more physi-
ological conditions (Chen et al., 2012; Parker et al., 2012b), it 
may be possible that even viral particles trigger NET forma-
tion. In addition, Jenne et al. (2013) used systemic administra-
tion of LPS to induce protection from viral infection. It is 
unclear whether that response induces specific activation of 
neutrophils and whether the DNase treatment used only 
affects neutrophil-derived NETs. Nevertheless, though addi-
tional studies in the field are warranted, these two studies (to-
gether with additional ones showing priming of virus-specific 
T cells by neutrophils; Duffy et al., 2012) open up new ave-
nues on the role of neutrophils in the host defense against 
viral pathogens.
Neutrophils in infection with intracellular pathogens
The traditional view is that neutrophils eradicate extracellular 
bacteria and fungi, whereas intracellular pathogens such as 
mycobacteria are primarily dealt with by macrophages. 
Although prior studies indicated possible roles for neutrophils 
during mycobacterial infection (Appelberg, 2007; Lowe et al., 
2012), recent studies provided important novel insights into 
the role of neutrophils in the fight against intracellular patho-
gens. Analysis of healthy human individuals who have been 
in contact with tuberculosis patients revealed strong inverse 
correlation between the risk of tuberculosis infection and 
2000s, both of them triggering intensive scrutiny and debate 
from the scientific community. Anthony Segal’s group pro-
posed an interesting molecular interplay whereby ion fluxes 
triggered by the NADPH oxidase would promote the anti-
microbial function of granule proteins (Reeves et al., 2002). 
Though many components of the proposed mechanism (such 
as the electrogenicity of the NADPH oxidase [Fig. 1, inset] 
providing driving force for other ion currents; Geiszt et al., 
1997; Schrenzel et al., 1998; Rada et al., 2005) are generally 
accepted, it is still debated whether and to what extent ion 
fluxes that compensate for the activity of the NADPH oxidase 
contribute to the antibacterial effects of granule enzymes 
(Geiszt et al., 2001; Rada et al., 2004; Rada et al., 2005; 
Femling et al., 2006; Essin et al., 2009). Another interesting 
and similarly provocative idea was that, in addition to intra-
phagosomal killing, neutrophils may also be able to expel their 
nuclear content (including DNA) complexed with granule 
proteins into the extracellular space and that this complex 
(NETs) may inhibit microbial growth without phagocyto-
sis of the pathogen (Brinkmann et al., 2004; Fig. 1). Though 
neutrophil-derived extracellular DNA has long been known 
to be present at the site of infection (in part as a component 
of pus formation) and NET formation has recently been 
directly visualized during bacterial infection in vivo (Yipp 
et al., 2012; McDonald et al., 2012), the contribution of NET 
formation to antibacterial host defense and killing is still under 
intensive debate (Brinkmann and Zychlinsky, 2012; Menegazzi 
et al., 2012; Nauseef, 2012; Parker et al., 2012a).
Neutrophils are short-lived cells that die within a limited 
time after entering the circulation (Geering and Simon, 2011). 
In the absence of infection or inflammation, they die by a 
spontaneous apoptosis program (Geering and Simon, 2011; 
Witko-Sarsat et al., 2011), likely within 1 d (although some in-
vestigators propose this time to be up to 5 d; Pillay et al., 2010). 
Inflammatory signals are capable of prolonging the lifespan 
of the cells by several days, during which they release inflam-
matory mediators and contribute to the orchestration of 
the inflammatory response (Mantovani et al., 2011; Fig. 1). 
However, even under those conditions, neutrophils will 
soon die by apoptosis (or, possibly, NETosis), contributing 
to pus formation inside infected tissues. Once neutrophils die, 
another program for removal of dead neutrophils by macro-
phages is initiated (Bratton and Henson, 2011). Parallel to 
the inflammatory response, biochemical and transcriptional 
changes leading to the resolution of the inflammation begin 
(Serhan, 2007; Serhan et al., 2008; Soehnlein and Lindbom, 
2010), and this is further promoted by engulfment of the 
corpses of dead neutrophils by macrophages (El Kebir and 
Filep, 2010).
The role of neutrophils in antiviral host defense
Whereas neutrophils are critical for immunity against bacte-
rial and fungal pathogens, their role in antiviral host defense 
is much less appreciated. In a recent study, Saitoh et al. (2012) 
proposed a role for NETs in the control of HIV-1 infection. 
HIV-1 triggered NET formation by human neutrophils and 
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uncertain whether IL-10, the cytokine proposed to be re-
sponsible for most of the reported findings in mice (Zhang 
et al., 2009), is also released by human neutrophils (Davey 
et al., 2011).
The latest twist in the role of neutrophils in tuberculosis 
comes from a recent study on zebrafish (Yang et al., 2012). By 
monitoring mycobacterial infection, Yang et al. (2012) found 
that neutrophils did not interact with the microbes during 
the very first phase of infection but engulfed dying infected 
macrophages during early granuloma formation and killed 
the surviving intracellular pathogens. That study suggests 
that efferocytosis (the engulfment of dying cells) not only 
serves to clean up the site of infection but also contributes 
to containing the infection, at least in the case of mycobac-
terial challenge.
Another unexpected role for neutrophils in infectious 
diseases has been revealed by a recent study on malaria patho-
genesis (Porcherie et al., 2011). The authors showed that 
genetic deficiency of IgE- or FcRI-protected mice from 
cerebral malaria and death, but not parasitemia after infection 
with Plasmodium falciparum parasites. Interestingly, FcRI was 
dramatically up-regulated on circulating neutrophils after 
parasitic infection and FcRI-positive neutrophils became 
the dominant FcRI-positive leukocyte population in the 
brain. Importantly, depletion of neutrophils using the NIMP-
R14 anti-Gr1 antibody protected mice both from neurological 
signs of cerebral malaria and from malaria-induced death, 
but not from parasitemia, suggesting an important role for 
neutrophils in malaria pathogenesis (Porcherie et al., 2011). 
Although the mechanism whereby neutrophils contribute to 
cerebral manifestations of malaria is incompletely understood, 
the authors suggested that production of proinflammatory 
cytokines (e.g., IFN-) by neutrophils accumulating in the 
brain of infected animals leads to excessive inflammation 
and subsequent neurological signs that are characteristic of 
cerebral malaria.
Collectively, the aforementioned studies suggest that 
neutrophils may have a much wider (protective or some-
times pathogenic) role during infectious diseases than previ-
ously appreciated.
Neutrophils in the regulation of B and T cells
Neutrophils have long been seen as effector cells that have 
little influence on shaping the adaptive immune response. 
That view is being challenged by several recent reports.
Marginal zone B cells are unique B cells of the spleen 
that are located outside the germinal centers and close to the 
marginal sinus, thus closely positioned to the blood circula-
tion. Their primary function is the rapid initiation of T cell–
independent antibody responses to blood-borne microbes. 
Interestingly, a prior study revealed that neutrophils are one of 
the major cell types responsible for capturing and transporting 
circulating bacteria to the splenic marginal zone in mice (Balázs 
et al., 2002). Additionally, prior human studies showed that ac-
tivated (but not resting) neutrophils express the B cell–activating 
cytokine BAFF (also known as BLyS; Scapini et al., 2003) and 
peripheral blood neutrophil counts (Martineau et al., 2007). 
The authors also showed that ex vivo growth of mycobacteria 
in whole blood was dramatically increased upon neutrophil 
depletion, whereas neutrophil-derived antimicrobial peptides 
inhibited mycobacterial growth from in vitro bacterial cul-
tures (Martineau et al., 2007). Another recent study identified 
a unique blood transcriptional signature in human tuberculo-
sis patients that closely matched a putative type I and type II 
interferon-induced gene expression signature in neutrophils 
(Berry et al., 2010). This signature was clearly distinguishable 
from those in other diseases characterized by a major neutro-
phil component (such as Gram-positive bacterial infections) 
or by a type I IFN signature (such as SLE). Those two studies 
suggested that neutrophils actively fight against mycobacteria 
and may provide protection from infection.
A possible explanation for those findings is that neutro-
phils fight mycobacteria during and immediately after their 
entry into the organism. However, this may only be true for 
the initial contact with mycobacteria when neutrophils are 
able to prevent infection of the host, while macrophages “take 
over” when the bacilli reach intracellular compartments 
(Lowe et al., 2012). Indeed, neutrophils likely play an oppo-
site, pathogenic role during later stages of the disease, through 
at least two different mechanisms. First, neutrophils may serve 
as vectors for the systemic dissemination of the pathogens. 
Mouse neutrophils are able to acquire live mycobacteria at 
the site of infection and carry those microbes to the draining 
lymph nodes by migration within the lymphatic vasculature 
(similar to the migration of DCs in a general immune response; 
Abadie et al., 2005). Although this may promote antimicrobial 
host defense, an alternative scenario is that mycobacteria that 
escape killing and survive inside neutrophils use them as 
“Trojan horses” to help disseminate the bacteria to distant 
organs. This would be similar to the situation in leishmaniasis 
when neutrophils engulf parasites at the site of infection and 
deliver them to macrophages, which take up live Leishmania 
parasites during phagocytosis of apoptotic neutrophils (van 
Zandbergen et al., 2004; Peters et al., 2008; John and Hunter, 
2008). The second mechanism for the contribution of neu-
trophils to the chronic phase of tuberculosis may be related 
to their role in infection-induced tissue damage. Cruz et al. 
(2010) suggested that excessive release of IL-17 during re-
peated mycobacterial exposure leads to neutrophil recruit-
ment and neutrophil-mediated tissue damage in mice. This 
response appears to be attenuated by IFN- production dur-
ing a normal antimycobacterial immune response (Nandi and 
Behar, 2011), indicating that neutrophil accumulation and the 
resulting tissue damage may be caused by the failure of the 
immune system to contain the infectious agents.
The dual role of neutrophils in tuberculosis is also re-
flected in another recent study, suggesting that neutrophils 
down-regulate inflammation at early stages of mycobacterial 
infection but contribute to inflammation and mycobacterial 
clearance during chronic tuberculosis in experimental mice 
(Zhang et al., 2009). The importance of those findings in 
human pathology has yet to be assessed, in part because it is 
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mice than in normal specific pathogen–free animals, indicat-
ing that microbial products, likely originating from the com-
mensal flora, play an important role in the accumulation of 
splenic marginal zone neutrophils. Importantly, human pa-
tients suffering from various congenital defects of neutrophil 
development or function had normal total circulating B cell 
numbers but strongly reduced numbers of circulating mar-
ginal zone B cells, and their serum levels of antibodies against 
T cell–independent antigens were significantly reduced de-
spite normal levels of antibodies against T cell–dependent 
antigens. Collectively, the elegant study of Puga et al. (2011) 
revealed a potentially important immunological and immune-
homeostatic mechanism whereby splenic neutrophils may 
facilitate the antibody response of marginal zone B cells to 
T cell–independent microbial antigens. This mechanism re-
quires the reprogramming of circulating neutrophils by micro-
bial signals, as well as the neutrophil-derived BAFF, APRIL, 
and IL-21 cytokines. Further studies will be required to de-
termine the full importance of this mechanism in immune 
defense and to more closely define the nature and develop-
mental stage of the proposed B cell helper neutrophil popula-
tion relative to their circulating counterparts.
The role of neutrophils in the regulation of T cell func-
tion appears to be more complex and less well understood. 
Regulation of T cells by myeloid cells primarily occurs via 
that neutrophils are a major source of the BAFF-related, 
B cell–stimulating cytokine APRIL in B cell lymphomas 
(Schwaller et al., 2007) and mucosal plasma cell niches (Huard 
et al., 2008; Scapini et al., 2008). A recent work by Puga et al. 
(2011) revealed an intricate relationship between neutrophils 
and marginal zone B cells and proposed that this interaction 
mediates T cell–independent antibody responses through 
BAFF and APRIL (Fig. 2 A). The authors found a large 
number of neutrophils around the splenic marginal zone in 
humans, macaques, and mice. In mice, splenic but not circu-
lating neutrophils were able to strongly activate marginal zone 
B cells, whereas they had limited stimulatory effect on follicular 
B cells and even inhibited CD4+ T cells. Importantly, splenic 
neutrophils promoted B cell survival, antibody production, 
class switching to IgG and IgA, and somatic hypermutation, 
indicating that they qualify to be bona fide B helper cells. 
Splenic, but not circulating, neutrophils express large amounts 
of BAFF, APRIL, and IL-21, and all those cytokines were 
required for the stimulatory effect on marginal zone B cells. 
Circulating neutrophils acquired the ability of activating mar-
ginal zone B cells upon exposure to splenic sinusoidal endo-
thelial cells in the presence of microbial signals in vitro. The 
colonization of the splenic marginal zones by neutrophils pri-
marily occurred soon after birth in humans, and marginal 
zone neutrophils were significantly less abundant in germ-free 
Figure 2. Novel interactions of neutro-
phils with other immune cells. (A) Neutro-
phils (PMN) accumulate in the splenic 
marginal zone upon microbial challenge and 
facilitate the antibody production and matu-
ration of marginal zone B cells (MZB) in re-
sponse to T cell–independent (TI) antigens. 
(B) Neutrophils participate in a vicious cycle 
during autoimmune disease (e.g., SLE) patho-
genesis by releasing NETs that trigger pDCs to 
release IFN-, which then promotes antibody 
production by B cells (B). (C) Neutrophils may 
directly present antigens to T cells (T) and  
they also activate DCs and deliver antigens to 
them. (D) Neutrophils and DCs jointly activate 
NK cells (NK).
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polarization of T cells (Bennouna and Denkers, 2005; van 
Gisbergen et al., 2005b; Megiovanni et al., 2006). The inter-
action between human neutrophils and DCs has been pro-
posed to be at least in part mediated by a unique interaction 
between DC-SIGN and Mac-1 on the neutrophil surface 
(van Gisbergen et al., 2005a,b; Boudaly, 2009; Yang et al., 
2009; Fig. 2 C).
Recent studies have also revealed another unique role of 
neutrophils in DC activation during the pathogenesis of 
autoimmune diseases such as systemic lupus erythematosus 
(SLE) or type I diabetes (T1D). Characteristic features of SLE, 
an immune complex–mediated systemic autoimmune disease 
characterized by autoantibodies against nuclear antigens, 
include the chronic activation of plasmacytoid DCs (pDCs) 
leading to constitutive secretion of type I interferons such as 
IFN- (Obermoser and Pascual, 2010) and the presence of 
circulating low-density granulocytes reminiscent of immature 
neutrophils (Bennett et al., 2003; Kaplan, 2011). Two recent 
studies on human patients shed novel light on the role of 
pDCs, type I interferons, and neutrophils in the core patho-
genesis of SLE (Lande et al., 2011; Garcia-Romo et al., 2011; 
Fig. 2 B). SLE neutrophils were more prone to cell death by 
NETosis and to release NETs into the extracellular environ-
ment. Those NETs contained self-DNA in complex with 
antimicrobial proteins including LL37 (the C-terminal peptide 
derived from the human cathelicidin hCAP-18) and were 
able to activate pDCs through the TLR9 pathway and to trigger 
type I interferon production. This led to activation of B cells 
that produced autoantibodies against both self-DNA and the 
antimicrobial peptides. Type I interferons and immune com-
plexes triggered further activation of neutrophils releasing 
more NETs (Lande et al., 2011), establishing a vicious cycle 
at the core of SLE pathogenesis (Fig. 2 B). Low-affinity Fc-
receptors (such as the human FcRIIA) and TLR7 were re-
quired for immune complex-induced neutrophil activation 
(Garcia-Romo et al., 2011). FcRIIA may also participate 
in the uptake of DNA-containing immune complexes by 
pDCs (Båve et al., 2003), followed by recognition of DNA-
antimicrobial peptide complexes by the TLR9 pathway 
(Garcia-Romo et al., 2011; Lande et al., 2011). It should be 
noted that pDCs do not recognize self-DNA under non-
pathological conditions. However, the presence of LL37 in 
the DNA complexes in NETs prevented degradation of 
DNA, leading to delivery of DNA to early endosomes of 
pDCs, where it could activate the TLR9 pathway (Lande et al., 
2007; Lande et al., 2011). Therefore, the unique composition 
of NETs makes them a suitable candidate to trigger pDC ac-
tivation in the core of SLE pathogenesis. These results are 
also in line with a proposed contribution of NET degrada-
tion defects to SLE pathogenesis (Yasutomo et al., 2001; 
Hakkim et al., 2010), as well as a previous study on the presence 
of NET formation in autoimmune small vessel vasculitis 
(Kessenbrock et al., 2009).
The role of neutrophils in pDC activation and develop-
ment of autoimmune diseases has also recently been proposed 
in the pathogenesis of T1D, which is also thought to involve 
antigen presentation by DCs or macrophages, supported by 
the migration of antigen-loaded DCs to the draining lymph 
nodes. Interestingly, human and mouse neutrophils also ap-
pear to be able to carry antigens to the lymph nodes by 
migrating in lymphatic vessels in a CCR7-dependent manner 
(Abadie et al., 2005; Maletto et al., 2006; Beauvillain et al., 
2011). A recent study also showed that vaccinia virus-specific 
CD8+ T cells emerge in the bone marrow and, based on fluor-
escence tracking and Ly6G antibody-mediated depletion 
approaches, identified neutrophils as the cells transporting the 
antigen from the dermis to the bone marrow (Duffy et al., 
2012). Neutrophils also express molecules required for anti-
gen processing and presentation to T cells (Ashtekar and Saha, 
2003; Beauvillain et al., 2007). Late precursors committed to 
the neutrophil lineage are also important precursors of DC 
development (Oehler et al., 1998). Furthermore, mouse neu-
trophils are able to cross-prime naive T cells, i.e., present ex-
tracellular antigens on MHC class II molecules to CD8+  
T cells (Beauvillain et al., 2007), and also prime antigen-specific 
Th1 and Th17 cells (Abi Abdallah et al., 2011). The transport 
of antigens from the periphery to the site of T cell priming 
and the direct priming/activation of antigen-specific T cells 
in an MHC-restricted manner raise the possibility that neu-
trophils may possibly even perform some level of classical 
antigen-presenting cell function (Fig. 2 C).
Although the aforementioned studies suggest that neu-
trophils positively regulate antigen-specific T cell responses, 
several works indicate a negative role for the neutrophil lin-
eage in T cell function. As mentioned above, splenic neutro-
phils negatively regulate CD4+ T cell function in mice (Puga 
et al., 2011). A subset of human neutrophils also inhibits T cell 
responses during acute systemic inflammatory reactions such 
as bacterial sepsis (Pillay et al., 2012). Using Ly6G antibody-
mediated depletion and G-CSF receptor-deficient mice, a 
recent study showed that neutrophils prevent the spread of 
the T cell response to distal lymph nodes during immuniza-
tion (Yang and Unanue, 2013). In addition, a large number of 
immature myeloid cells with inhibitory functions on T cells 
and other immune function, termed myeloid-derived sup-
pressor cells (MDSCs), can be observed in cancer patients 
and in various other infectious or inflammatory conditions 
(Gabrilovich and Nagaraj, 2009). A subset of those cells 
(so-called granulocytic MDSCs) share many characteristics with 
(immature) neutrophils, highlighting the possibility of nega-
tive regulation of T cell function by the neutrophil lineage.
Regulation of DCs by neutrophils
The effect of neutrophils on adaptive immunity is not only 
mediated by direct effects on B and T cells, but also by affect-
ing the function of DCs. Indeed, mouse neutrophils are capa-
ble of, and required for, the activation of DCs during microbial 
infection (Bennouna et al., 2003; Charmoy et al., 2010). 
Human and mouse studies suggest that neutrophils directly 
interact with DCs, which may lead to various responses in-
cluding DC maturation and activation, access to antigens cap-
tured by neutrophils, or DC-mediated proliferation and TH1 
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before and a functional cooperation between the two cell types 
had been proposed (Costantini and Cassatella, 2011). The 
most detailed study tested the role of neutrophils in Legionella 
pneumophila infection in mice, aiming to understand why 
neutrophils, which are not capable of killing Legionella species 
themselves, still play a role in clearing L. pneumophila infection 
(Spörri et al., 2008). The authors confirmed that depletion 
of neutrophils by anti-Gr1 antibodies attenuated host defense 
against Legionella but it also blocked IFN- production 
by NK cells. Using elegant genetic approaches and mixed 
bone marrow chimeric studies, they showed that IFN- pro-
duction by NK cells was directly stimulated by IL-18 released 
from neutrophils in response to Legionella infection (Spörri 
et al., 2008), suggesting that interactions between neutrophils 
and NK cells may be of functional importance (Fig. 2 D).
A recent study has provided novel and unexpected 
genetic evidence for the role of neutrophils in regulating 
NK cell homeostasis and function (Jaeger et al., 2012). The 
authors set up a random chemical mutagenesis screen to 
identify novel mutant mouse strains with defective NK cell 
development and function. They identified a mutation called 
Genista, which led to hyporesponsive NK cells as indicated 
by reduced in vitro and in vivo responses to target cells and 
ligation of NK cell–activating receptors (Jaeger et al., 2012). 
Interestingly, adoptive transfer studies revealed hyporespon-
siveness of wild-type NK cells transferred to Genista recipi-
ents, indicating that the NK cell phenotype was, at least in 
part, caused by an environmental, non–cell autonomous 
defect. In parallel studies, the Genista mutation was identified 
to be a hypomorphic missense mutation of the Gfi-1 transcrip-
tion factor, leading to defective terminal differentiation of 
neutrophils (as indicated by the absence of fully mature neu-
trophils in the periphery) without negatively affecting T or 
B cell lineages or other myeloid (monocyte, macrophage, DC) 
compartments (Ordoñez-Rueda et al., 2012; Jaeger et al., 
2012). This was in line with the similar, though more severe, 
defect in neutrophil maturation in mice with complete dis-
ruption of the Gfi-1–encoding gene (Karsunky et al., 2002; 
Hock et al., 2003) and congenital neutropenia in human pa-
tients carrying a dominant–negative Gfi-1 mutation (Person 
et al., 2003). To further confirm the role of neutrophils 
in NK cell function, the authors showed that depletion of 
neutrophils by an anti-Ly6G antibody also reduced the func-
tional responsiveness of NK cells (Jaeger et al., 2012). Further 
studies revealed that both the Genista mutation and the Ly6G 
antibody-mediated depletion led to defective terminal matu-
ration and poor survival of NK cells. The authors also re-
ported that patients suffering from various forms of congenital 
or acquired (autoimmune) neutropenia had higher percent-
ages of NK cells showing an immature phenotype and reduced 
responsiveness to target cells (Jaeger et al., 2012). Interest-
ingly, one of the patients with autoimmune neutropenia 
showed a remission during the course of the study, during 
which normalization of peripheral neutrophil count and NK 
cell function occurred in parallel. Collectively, those results 
suggest that neutrophils likely play a role in regulating the 
type I interferon production by pDCs (Diana et al., 2013). 
Diana et al. (2013) reported early infiltration of the pancreas 
of young nonobese diabetic (NOD) mice with neutrophils, 
B-1a B cells, and pDCs. Pancreatic -cell death triggered 
production and release of anti-DNA IgG antibodies from 
B-1a cells, which formed DNA–anti-DNA immune com-
plexes and triggered, supposedly in an Fc-receptor–dependent 
manner, neutrophil NET formation and the release of the 
murine cathelicidin peptide CRAMP. The DNA–anti-DNA 
immune complexes and CRAMP then activated pDCs 
through TLR9 to release IFN-, which is proposed to trigger 
further T cell–mediated autoimmune processes. In agreement 
with the proposed role of neutrophils in the development 
of T1D, injection of 2-wk-old NOD mice with the NIMP-
R14 anti-Gr1 antibody reduced later development of diabe-
tes in those animals (Diana et al., 2013).
The aforementioned studies suggest an unexpected role 
for neutrophils in very early phases of autoimmune disease 
pathogenesis through triggering of type I interferon produc-
tion by pDCs. There are, however, several open questions that 
need to be addressed. First, it is widely believed that NET 
formation requires the NADPH oxidase (Fuchs et al., 2007); 
therefore SLE pathogenesis would be expected to rely on 
the presence of this enzyme. However, deficiency of the 
NADPH oxidase component Nox2 exacerbated, rather than 
inhibited disease pathogenesis in lupus-prone mice (Campbell 
et al., 2012), arguing against the role of NETs in SLE patho-
genesis. This issue is further complicated by NADPH oxidase-
independent NET formation proposed by other recent studies 
(Chen et al., 2012; Parker et al., 2012b). Second, although 
Fc-receptor polymorphisms have been shown to be associ-
ated with human SLE (Takai, 2005), no such associations have 
been reported for T1D (even though NOD mice lacking 
activating Fc-receptors are partially protected from diabetes 
development; Inoue et al., 2007). Therefore, the role of the 
aforementioned mechanism in diabetes development may not 
be entirely relevant to human patients. Third, because NETs 
are likely often formed during bacterial infections (Yipp et al., 
2012; McDonald et al., 2012), it is unclear how autoimmunity 
is avoided under normal healthy conditions. Nevertheless, the 
aforementioned mechanism provides an attractive model for 
the role of neutrophils in autoimmune disease pathogenesis 
that will merit further investigation. A similar mechanism 
has also been proposed during development of atherosclero-
sis (see The role of neutrophils in atherosclerosis), and NETs 
have also been suggested to participate in the pathogenesis 
of rheumatoid arthritis by displaying citrullinated auto-
antigens in an inflammatory environment (Khandpur et al., 
2013), further extending the importance of such a pathway in 
human diseases.
Neutrophils in the regulation of NK cell homeostasis
NK cells are innate lymphocytes with critical roles in the 
elimination of virus-infected and tumor cells. In vitro inter-
actions between neutrophils and NK cells were described 
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and that this component is sufficient to trigger a full-blown 
anaphylaxis response. Additional experiments indicated that 
the neutrophil-dependent anaphylactic reaction was medi-
ated primarily by PAF rather than histamine (Jönsson et al., 
2011). Importantly, active systemic anaphylaxis could be re-
stored by adoptive transfer of human neutrophils to FcR/ 
animals (Jönsson et al., 2011) or by transgenic expression of 
human FcRIIA in FcR/ mice (Jönsson et al., 2012), sug-
gesting that human neutrophils may also be able to mediate 
systemic anaphylactic reactions.
The various forms of skin allergies comprise a major 
group of localized allergic diseases. As with other allergic 
diseases, their mechanism can also be divided into two con-
ceptually different phases, the sensitization phase (leading 
to priming of the adaptive immune system) and the elicita-
tion phase (causing local tissue damage through activation of 
the primed adaptive immune cells). They are also often com-
plicated by additional inflammatory insults, such as chemi-
cally induced tissue damage in allergic contact dermatitis or 
mechanical damage caused by itching-induced scratching 
in atopic dermatitis. Several recent studies indicate an im-
portant role for neutrophils in skin allergies. Anti-Gr1 anti-
body treatment has been known to prevent ear swelling and 
T cell infiltration during contact hypersensitivity, a mouse 
model of allergic contact dermatitis (Dilulio et al., 1999). In 
a recent study, neutrophils expressing the LTB4-receptor 
BLT1 were found to be required for inflammation and re-
cruitment of allergen-primed T cells at the allergen challenge 
site in a novel mouse model of atopic dermatitis combining 
ovalbumin immunization and challenge with mechanical skin 
injury (reminiscent of itching-induced scratching; Oyoshi 
et al., 2012).
Both of the aforementioned studies revealed important 
roles for neutrophils in the elicitation phase of allergic skin 
inflammation. However, although innate immune mecha-
nisms likely also play important roles in DC activation and 
T cell priming during the earlier and conceptually different 
sensitization phase of allergic skin diseases (Kaplan et al., 
2012), no studies on the role on neutrophils in that phase 
have been completed yet. Interestingly, our own recent studies 
(unpublished data; published in abstract form in Weber et al., 
2012) suggested an important role for neutrophils in the 
sensitization phase of contact hypersensitivity. In that study, 
we found that Ly6G antibody-mediated depletion of neutro-
phils, selectively during the sensitization phase, abrogated 
the contact hypersensitivity reaction, and diminished DC 
activation and priming of allergen-specific T cells. In addition, 
lymph node cells from allergen-sensitized mice that were 
previously treated with neutrophil-depleting anti-Ly6G anti-
bodies or were genetically deficient of neutrophils because of 
a myeloid-specific deletion of the Mcl-1 protein (Dzhagalov 
et al., 2007) were unable to transfer sensitivity toward con-
tact allergens to normal naive recipients (Weber et al., 
2012). Therefore, neutrophils appear to be critical players in 
both the sensitization and elicitation phases of allergic skin 
inflammatory reactions.
terminal differentiation and functional responsiveness of NK 
cells (Fig. 2 D). The colocalization and direct physical inter-
action of the two cell types in mouse lymphoid organs (Jaeger 
et al., 2012) and inflamed human tissues (Costantini et al., 
2011) suggest that neutrophils may directly regulate the NK 
cell compartment.
Although the aforementioned studies indicate an impor-
tant role for neutrophils in the regulation of NK cell function, 
the contribution of a third cell type (such as DCs) in this 
interaction cannot be excluded. Indeed, besides neutrophil- 
derived IL-18, IFN- production by NK cells upon Legionella 
infection also required IL-12 derived from DCs as a result of 
their reciprocal regulation with NK cells (Spörri et al., 2008; 
Fig. 2 D). A tripartite complex formed by neutrophils, NK 
cells and a minor subset of DCs (slanDCs) has also been ob-
served in human samples (including inflammatory lesions in 
Crohn’s disease and psoriasis) and was proposed to promote 
IFN- production by NK cells (Costantini et al., 2011).
Collectively, neutrophils have recently emerged as poten-
tially important regulators of NK cell homeostasis and activa-
tion, possibly in close relationship with DCs.
Neutrophils in allergy and anaphylaxis
Allergic and anaphylactic reactions are adaptive immune re-
sponses triggered by repeated exposure to allergens, and are 
typically characterized by vascular reactions such as vasodila-
tion and edema formation. Several recent studies suggest un-
expected roles for neutrophils in those reactions.
The prevailing paradigm of anaphylaxis development is 
that allergen-induced cross-linking of IgE molecules bound 
to Fc-receptors on mast cells and basophils triggers hista-
mine release and subsequent systemic vasodilation (Khan and 
Kemp, 2011). Although this mechanism is likely responsible 
for the majority of anaphylactic reactions, several observations 
indicate that alternative mechanisms, possibly mediated by 
IgG and cellular lineages other than mast cells and basophils, 
may also be at play (Finkelman, 2007; Tsujimura et al., 2008; 
Ohnmacht et al., 2010). Jönsson et al. (2011) identified neu-
trophils as important players of active and IgG-induced 
passive systemic anaphylaxis in experimental mice (Fig. 3 A). 
Passive systemic anaphylaxis triggered by IgG antibodies was 
blocked by neutrophil depletion using the RB6-8C5 anti-
Gr1 antibody. Active systemic anaphylaxis was partially 
reduced by anti-Gr1 antibodies alone, and it was nearly 
completely blocked by simultaneously depleting both neu-
trophils and basophils (Jönsson et al., 2011). Interestingly, mice 
lacking all activating Fc- and Fc-receptors except FcRIV 
were able to mount normal active anaphylactic reactions 
which were, however, completely blocked by anti-Gr1 anti-
bodies. Adoptive transfer of wild-type neutrophils rescued 
anaphylaxis development in FcR -chain-deficient animals 
(which lack all activating Fc- and Fc-receptors including 
FcRIV, and fail to mount active systemic anaphylaxis). Those 
results suggest that neutrophils are responsible for the FcRIV-
mediated component of active systemic anaphylaxis in mice 
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perforin-mediated translocation of granzymes), it is unclear 
how this would happen in case of neutrophil elastase and how 
elastase would selectively cleave IRS-1 without wreaking havoc 
inside the target cell. The problem of protease-mediated pro-
tein degradation during lysis of neutrophil-containing bio-
logical samples is also well known in the scientific community; 
therefore more careful studies to exclude the possibility of 
IRS-1 degradation during sample preparation are warranted.
Another study mentioned earlier suggests a role for neu-
trophils in the pathogenesis of T1D, an autoimmune disease 
caused by degradation of pancreatic -cells (Diana et al., 
2013). In that study, neutrophils were shown to participate in 
the activation of type I cytokine production by pDCs and 
in subsequent activation of the adaptive immune response 
(Diana et al., 2013). That study places neutrophils high in the 
hierarchy of autoimmune disease pathogenesis, participating 
in the shaping of the adaptive immune response.
Collectively, although the studies on the role of neutro-
phils in diabetes and related metabolic diseases may open up 
new directions of research that may significantly improve our 
understanding of the inflammatory origin of metabolic dis-
eases, they also raise several additional questions and concerns 
that have yet to be addressed.
The role of neutrophils in atherosclerosis
Cardiovascular diseases are among the most prevalent human 
diseases and are the leading causes of death in developed 
countries. Several recent studies suggest that neutrophils play 
an important role in those diseases, in particular the develop-
ment and progression of atherosclerosis and the pathogenesis 
of thrombosis.
The role of neutrophils in metabolic diseases
Metabolic diseases such as diabetes and obesity are among the 
largest health challenges of the 21st century. Several recent stud-
ies suggest unexpected roles for neutrophils in those diseases.
Obesity and the resulting insulin resistance is one of the 
major causes of metabolic syndrome and type 2 diabetes. It has 
long been known that obesity has an important inflammatory 
component and that this contributes to the resulting insulin re-
sistance (Gregor and Hotamisligil, 2011). The primary cell type 
responsible for inflammation in obesity has been considered to 
be the inflammatory macrophage in adipose tissues (Olefsky 
and Glass, 2010). However, neutrophils have also been shown 
to be recruited to adipose tissues early during the course of 
diet-induced obesity in mice (Elgazar-Carmon et al., 2008) 
and to be present in increased numbers in the fatty liver of 
obese human patients (Rensen et al., 2009). A recent report 
has confirmed the dramatic accumulation of adipose tissue 
neutrophils, as well as the increased presence and activity of 
the neutrophil-specific protease neutrophil elastase, during 
high-fat diet in experimental mice (Talukdar et al., 2012). 
Importantly, the pharmacological inhibition or genetic deletion 
of neutrophil elastase led to improved in vivo glucose tolerance 
and insulin sensitivity, likely due to improved responsiveness of 
liver and adipose tissue cells to insulin. The authors proposed 
that neutrophil elastase gains access to the intracellular space 
(endocytic compartments) of hepatocytes and degrades insulin 
receptor substrate 1 (IRS-1), leading to attenuation of insulin 
signal transduction pathways (Talukdar et al., 2012; similar to a 
mechanism previously proposed to occur in lung cancer 
cells; Houghton et al., 2010). Although there is precedent for 
translocation of proteases through cell membranes (such as 
Figure 3. Novel functions of neutrophils in vascular diseases. (A) Neutrophils (PMN) mediate an alternative pathway of anaphylactic reaction 
which is distinct from the classical pathway mediated by mast cells or basophils. (B) Sequential recruitment of platelets, neutrophils, and monocytes 
(Mono) participates in the pathogenesis of atherosclerosis. (C) Neutrophils contribute to coagulation and thrombosis by releasing tissue factor and inhibi-
tors of the tissue factor pathway inhibitor (TFPI), as well as the procoagulant NETs.
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adhesion is likely mediated by interaction between 2-integrins 
and ICAM-1.
It should be mentioned that another recent study on vas-
cular healing after wire injury, a mouse model of the vascular 
injury triggered by insertion of an arterial stent, placed the 
role of neutrophils in a different perspective (Soehnlein et al., 
2011). Ly6G antibody-mediated depletion of neutrophils or 
genetic deficiency of CRAMP inhibited endothelial re-
generation and promoted neointima formation (the major 
cause of arterial restenosis) after vessel injury, whereas LL37 
promoted endothelial recovery in an in vitro wound-healing 
assay (Soehnlein et al., 2011). Most importantly, covalent 
coating of arterial stents with LL37 significantly reduced in-
stent stenosis (Soehnlein et al., 2011). Those results suggest 
that neutrophils and neutrophil-derived cathelicidins may play 
a protective role during vascular healing after stent-mediated 
vascular damage and raise the possibility that LL37 treatment 
may reduce in-stent stenosis after stent insertion.
The aforementioned studies suggest potentially important 
roles for neutrophils in atherosclerosis and related vascular 
diseases. However, additional work will be required to delin-
eate the exact mechanism of how and in which phase and 
spatiotemporal order neutrophils participate in plaque forma-
tion. For example, do neutrophils get activated inside or outside 
the vasculature? How do intravascular events promote plaque 
formation under the endothelium? Are the roles of neutro-
phils in initial monocyte adhesion and eventual plaque de-
stabilization related or independent events? Although plaque 
formation and stent restenosis likely occur through different 
mechanisms, the opposing effect of neutrophils and CRAMP/
LL37 on those two endothelial damage-associated processes 
may also require additional mechanistic explanation. The role 
of CCR5 in neutrophil activation also raises questions, as this 
receptor is not expressed on neutrophils at high levels (although 
increased expression was shown upon apoptosis and at the site 
of inflammation; Ariel et al., 2006; Hartl et al., 2008).
Neutrophils in thrombus formation
Arterial or venous thrombosis is another major complication 
of vascular diseases, and causes significant morbidity and 
mortality worldwide. Several recent studies suggest that neu-
trophils may play a major role in triggering thrombosis in 
experimental mice. 
Neutrophils were found to be the first cell type to adhere 
to the site of endothelial injury in both arterial and venous 
thrombosis models (Darbousset et al., 2012; von Brühl et al., 
2012), and their accumulation at the site of vessel injury 
(along with that of monocytes) preceded the activation 
of platelets (Darbousset et al., 2012). Importantly, thrombus 
formation was dramatically reduced upon depletion of neu-
trophils by anti-Ly6G antibodies in a flow restriction–induced 
venous thrombosis model (von Brühl et al., 2012) or by anti-Gr1 
antibodies in laser-induced microvascular injury (Darbousset 
et al., 2012). Whereas contact of plasma proteins with extra-
vascular tissue factor is the primary trigger of thrombus for-
mation upon vessel injury, the source of prothrombotic agents 
It has long been appreciated that atherosclerosis results 
from chronic inflammation of the vascular wall (Hansson, 
2005). Recent reports indicate that neutrophils are present in 
unique areas of atherosclerotic plaques in both humans and 
mice (Naruko et al., 2002; Ionita et al., 2010; Drechsler et al., 
2010; Rotzius et al., 2010) and that their presence correlates 
with poor prognosis and signs of plaque destabilization in 
human patients (Naruko et al., 2002; Ionita et al., 2010). 
Importantly, depletion of neutrophils by antibodies against 
Ly6G strongly reduced the area of atherosclerotic lesions in 
apolipoprotein E-deficient (ApoE/) mice fed a high-fat 
diet for 4 wk, suggesting an important role for neutrophils 
in atherosclerotic plaque formation (Drechsler et al., 2010). 
A recent study provided additional support for the role of 
neutrophils in atherosclerosis, showing that the genetic defi-
ciency of CRAMP, a member of the cathelicidin family of 
antimicrobial peptides expressed in neutrophils, leads to re-
duced atherosclerotic lesion size in ApoE/ mice fed a high-
fat diet (Döring et al., 2012a). CRAMP and the homologous 
human cathelicidin peptide LL37 (the C-terminal portion of 
its precursor hCAP-18) promoted the adhesion of classical 
(inflammatory) monocytes to the vessel wall in mice, and this 
was inhibited by antagonists of formyl-peptide receptors, the 
receptors thought to be responsible for cathelicidin-mediated 
leukocyte migration (Döring et al., 2012a). In addition, acti-
vation of pDCs by complexes of cathelicidins with extracel-
lular DNA from neutrophils or other dying cells may also 
contribute to atherosclerosis development in mice (Döring 
et al., 2012b) in a manner similar to that proposed for the 
pathogenesis of SLE and T1D (Lande et al., 2011; Garcia-
Romo et al., 2011; Talukdar et al., 2012). The recruitment of 
neutrophils to the inflamed mouse arterial wall could also be 
reduced by platelet depletion or by the genetic deletion of 
CCR5, the receptor for the platelet-derived CCL5 (RANTES) 
chemokine (Drechsler et al., 2010) which is also required 
for atherosclerotic plaque formation (Braunersreuther et al., 
2007). The release and deposition of CCL5 appears to be de-
pendent on P-selectin on platelets (Huo et al., 2003; Drechsler 
et al., 2010). Platelets were previously proposed to participate 
in atherosclerotic plaque formation (Massberg et al., 2002; 
Huo et al., 2003) and platelet-derived CCL5 was shown to 
promote monocyte adhesion to the luminal surface of early 
atherosclerotic lesions in the inflamed arterial wall in mice 
(von Hundelshausen et al., 2001; Huo et al., 2003). Mice lack-
ing P-selectin, CD18, or ICAM-1 were previously shown to 
have reduced atherosclerotic plaque formation (Johnson et al., 
1997; Nageh et al., 1997; Collins et al., 2000). Collectively, 
atherosclerotic plaque formation likely involves the sequential 
recruitment of platelets, neutrophils, and monocytes, whereby 
platelet-derived CCL5, acting on CCR5, is at least partially 
responsible for neutrophil recruitment and neutrophil pro-
motion of monocyte recruitment by cathelicidin-induced 
activation of formyl-peptide receptors (Fig. 3 B). Platelet 
P-selectin is likely involved in platelet deposition (although 
an additional role of endothelial P-selectin in adhesion of leu-
kocyte rolling cannot be excluded) and neutrophil/monocyte 
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Additional subjects not discussed in detail
Several topics of major importance could not be covered in 
detail in this review. A brief discussion below points to some 
of those topics, with key references for further reading.
The role of neutrophils in tumor biology has long been 
appreciated (Pekarek et al., 1995). There has been several re-
cent developments in the field such as the polarization of 
tumor-associated neutrophils by TGF- (Fridlender et al., 
2009), a proposed role of neutrophil elastase in tumor growth 
(Houghton et al., 2010), the inhibition of tumor metastasis 
by neutrophils (Granot et al., 2011), neutrophils in cancer- 
induced thrombosis (Demers et al., 2012), the role of neu-
trophil-derived factors in maintaining B cell lymphoma 
(Schwaller et al., 2007), the potential role of neutrophils in 
tumor angiogenesis (Jablonska et al., 2010), and the role of 
histamine in preventing inflammation-induced carcinogenesis 
(Yang et al., 2011). Neutrophil-related immature myeloid 
cells called myeloid-derived suppressor cells also appear to 
play an immunosuppressive role in cancer (Gabrilovich and 
Nagaraj, 2009). The readers are referred to recent reviews 
for further information on this very interesting but diverse 
field of study (Gregory and Houghton, 2011; Fridlender and 
Albelda, 2012).
Besides the mostly positive roles of neutrophils in various 
physiological and pathological processes, neutrophils also 
play inhibitory or regulatory roles under certain conditions. 
Apoptosis of neutrophils triggers an active process promoting 
resolution of inflammation (Serhan, 2007; Serhan et al., 2008; 
Soehnlein and Lindbom, 2010). A subset of neutrophil- 
related immature myeloid cells called myeloid-derived sup-
pressor cells play a critical role in regulation of inflammation 
in cancer and potentially other conditions (Gabrilovich and 
Nagaraj, 2009). Neutrophils may also be able to produce 
the antiinflammatory cytokine IL-10 (Zhang et al., 2009; 
De Santo et al., 2010), though this is disputed in case of 
human neutrophils (Davey et al., 2011). Further information 
can be found in recent studies (Serhan et al., 2008; Gabrilovich 
and Nagaraj, 2009; Soehnlein and Lindbom, 2010; Mantovani 
et al., 2011).
Whereas many other leukocyte lineages have been subdi-
vided into various subsets, neutrophils have so far been mostly 
considered as a homogeneous population. That view is be-
ginning to change with novel functions ascribed to subpopu-
lations of neutrophils (Fridlender et al., 2009; Puga et al., 
2011; Pillay et al., 2012).
This review has focused on what neutrophils do rather 
than how they do it; therefore, most information regarding 
the mechanism of neutrophil function has been omitted. 
There are, however, exciting new discoveries in those fields, 
as well, such as various new mechanisms and cues guiding 
the migration of neutrophils (McDonald et al., 2010; Woodfin 
et al., 2011; Proebstl et al., 2012; Stark et al., 2013). Two brand 
new and possibly related studies also propose exciting 
and provocative ideas about how neutrophils may fight mi-
crobes: Timár et al. (2013) have recently proposed an antimi-
crobial function of neutrophil-derived microvesicles, whereas 
during arterial or venous thrombosis with an intact endothe-
lium has been poorly understood. After some debate about 
the presence of tissue factor in neutrophils (Maugeri et al., 
2005) it now appears that activated (but not resting) neutro-
phils express and release a significant amount of tissue factor 
(Maugeri et al., 2006; Fig. 3 C). Importantly, neutrophil-
mediated thrombus formation required tissue factor in a my-
eloid compartment (von Brühl et al., 2012; Darbousset et al., 
2012), and adoptive transfer studies suggested that neutro-
phils themselves may be an important source of tissue fac-
tor in a microvascular thrombosis model in mice (Darbousset 
et al., 2012).
The coagulation system is an important host defense sys-
tem in lower organisms, and there is also significant inter-
action between innate immunity and coagulation in higher 
vertebrates (Esmon, 2004). A recent study suggested that neu-
trophil serine proteases play an important role in the recipro-
cal coupling between innate immunity and coagulation in 
mice (Massberg et al., 2010; Fig. 3 C). The authors showed 
that the neutrophil-derived proteases neutrophil elastase and 
cathepsin G were required for thrombus formation after 
chemically induced vessel injury, as well as for activation of 
factor X upon co-incubation of neutrophils and platelets. The 
two enzymes inactivated the tissue factor pathway inhibitor 
protein, thereby promoting the coagulation cascade. Impor-
tantly, triggering of coagulation also prevented systemic dis-
semination of infectious Escherichia coli bacteria, suggesting 
the existence of a poorly appreciated level of innate host de-
fense in mammals.
The aforementioned study also suggested that neutrophil-
derived externalized nucleosomal structures (likely corre-
sponding to NETs) also play a procoagulant role in thrombosis 
(Massberg et al., 2010; Fig. 3 C). Indeed, NETs were shown 
to be able to trigger platelet activation and thrombus forma-
tion in vitro (Fuchs et al., 2010). A significant amount of 
extracellular DNA trap formation inside the thrombus could 
be observed upon flow restriction–induced venous thrombo-
sis in mice (Brill et al., 2012; von Brühl et al., 2012) and 
obstruction-induced venous thrombosis in baboons (Fuchs 
et al., 2010). Importantly, blocking NET formation by DNase 
treatment strongly reduced venous thrombus formation (Brill 
et al., 2012; von Brühl et al., 2012). Interestingly, various 
malignant states, including chronic myelogenous leukemia 
and various solid tumors, promote NET formation, which 
may be an important pathogenic mechanism of cancer- 
associated thrombosis (Demers et al., 2012). The proposed 
mechanism of NET-induced thrombus formation may in-
volve the activation of Factor XII by the negatively charged 
NET surface, with a direct effect on the stability of the fibrin 
network (i.e., independent of the activation of Factor XI; 
von Brühl et al., 2012).
Collectively, neutrophils may contribute to the thrombo-
sis and coagulation process by releasing tissue factor, even in 
the absence of vascular injury, by releasing serine proteases 
that inactivate the tissue factor pathway inhibitor, and/or by 
the formation of pro-coagulant NETs (Fig. 3 C).
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humans appears to be similar in many sense, there are also 
significant differences, such as the different expression of Fc- 
receptors (Bruhns, 2012) the apparent lack of IL-10 production 
by human but not murine neutrophils (Davey et al., 2011), as 
well as more widespread differences in the overall immune 
response (Mestas and Hughes, 2004; Seok et al., 2013). There-
fore, care should be taken when extrapolating mouse studies 
to human physiology and pathophysiology.
Concluding remarks and future directions
Neutrophils are the most abundant circulating leukocytes, yet 
their full spectrum of biological functions in immunity and 
beyond is just beginning to emerge, likely because of the dif-
ficulties in manipulating this terminally differentiated, short-
lived cell type. Studies published in the last few years propose 
that neutrophils play a much more diverse role than previ-
ously appreciated. Their putative novel roles described in this 
review include functions in viral infections and infections 
with intracellular pathogens; intricate interaction with various 
other components of the immune system; and roles in diseases 
such as autoimmune diseases, anaphylaxis, diabetes, athero-
sclerosis, and thrombosis. Although those studies have yet to 
be closely examined, scrutinized, and, hopefully, confirmed by 
the scientific community, they propose exciting novel avenues 
for the understanding of how our immune system contributes 
to health and disease.
The function of neutrophils in immune defense and 
their role in various immune-mediated (e.g., autoimmune; 
Németh and Mócsai, 2012) diseases result in significant inter-
est in this cell type in clinical medicine. The emerging infor-
mation on what neutrophils do and how they do it may 
hopefully be translated to important novel approaches of the 
diagnosis and treatment of diseases with a substantial neutro-
phil component.
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